نتایج جستجو برای: hematopoietic stem cell

تعداد نتایج: 1815814  

Journal: :iranian journal of blood and cancer 0
soheila zareifar associate professor of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences) babak abdolkarimi assistant professor of pediatric hematology-oncology, lorestan university of medical sciences, khoramabad, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی لرستان (lorestan university of medical sciences) mohamadreza bordbar associate professor of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences) mehran karimi professor of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences) fazl saleh fellowship of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences) omidreza zekavat associate professor of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences)

background: burkitt lymphoma is a common subtype of non-hodgkin lymphoma in children. it has a rapid and aggressive clinical course with frequent involvement of bone marrow and central nervous system. systemic chemotherapy is the mainstay of the treatment for this malignancy in children. in this systematic review, we discuss autologous and allogeneic hematopoietic stem cell transplantation (hsc...

Ali Akbar Movassagh Pour, Ali Akbar Pourfatollah, Masoud Soleimani, Mojdeh Salehnia,

The aim of this study was to isolate mouse embryonic stem cells from late blastocyst stage embryos and to use them as a model system for the study of hematopoietic induction outside the embryo by coculturing of embryonic stem cells with bone marrow stromal cells. Blastocyst stage embryos from pregnant NMRI mice were obtained and cultured for 1-2 days in DMEM medium. The inner cell masses formed...

Ali Jalili, Amir Atashi, Arezou Rahimi, Kaveh Tari, Mohammad Shahjahani, Saeid Abroun,

Hematopoietic stem/progenitor cells (HSPCs) which give rise to different blood cell types are present within the bone marrow microenvironment, especially in flat bones such as skull, vertebrae, pelvis and chest. Interacting factors such as stromal derived factor-1/CXCR4, very late antigen-4/vascular cell adhesion molecule-1, Lymphocyte function-associated antigen-1/ intercellular adhesion molec...

Journal: :international journal of hematology-oncology and stem cell research 0
kamran alimoghaddam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran mohammad jahani hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran seyyedasadollah mousavi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran babak bahar hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran masoud iravani hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran roshanak derakhshandeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

introduction: allogeneic hematopoietic stem cell transplantation (hsct) has been reported to be a successful curative treatment in aml patients. myeloablative conditioning (mac) is used more frequent as a preparing regimen. this study attempts to compare the outcome of patients who has received mac and reduced- intensity conditioning (ric). methods: totally, 618 patients with aml underwent hsct...

Thalassemia is an autosomal recessive disorder associated with defective synthesis of the α- or β-chain of hemoglobin. For β-thalassemia major patients, therapeutic options are either monthly red cell transfusions and chelation therapy or allogeneic stem cell transplant. Stem cell transplant is the only curative approach and success is inversely correlated with the degree of iron overload and h...

Bardia Khandany, Mehri Khatami, Mohammad Mehdi Heidari,

Induced pluripotent stem cells (iPSCs) are reprogrammed from somatic cells through numerous transcription factors. Human induced pluripotent stem cell approaches are developing as a hopeful strategy to improve our knowledge of genetic association studies and the underlying molecular mechanisms.  Rapid progression in stem cell therapy and cell reprogramming provides compelling reasons for its fe...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh professor of medicine, hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran. mehrzad mirzania hematologist and medical oncologist, cancer research center, cancer institute, tehran university of medical sciences, tehran, iran. naser kamalian professor of medicine, tehran university of medical sciences, tehran, iran. nahid sedighi associate professor of medicine, advanced diagnostic and interventional radiology, msk research group, tehran university of medical sciences, tehran, iran. parisima azimi tehran university of medical sciences, tehran, iran.

currently, hematopoietic stem cell transplantation (hsct) is the only curative option for patients with beta-thalassemia major, but liver iron overload in these patients will not decrease and hepatic fibrosis may still progress despite successful hsct. liver biopsy samples were taken from 14 patients (out of 25 patients) who underwent hsct. all patients met three criteria: negative hcv antibody...

Journal: :archives of clinical infectious diseases 0
kouros aghazadeh infectious diseases and tropical medicine research center, shahid behshti university of medical sciences, tehran, ir iran; infectious diseases and tropical medicine research center, shahid behshti university of medical sciences, tehran, ir iran seyed alireza nadji associate professor of medical virology, vrc, nritld, shahid beheshti university of medical sciences, tehran, ir iran shervin shokouhi department of infectious disease, loghman hospital, shahid beheshti university of medical sciences, tehran, ir iran payam tabarsi clinical tb and epidemiology research center, nritld, tehran, ir iran raziyeh niyati infectious diseases and tropical medicine research center, shahid behshti university of medical sciences, tehran, ir iran

conclusions chronic meningitis in immunocompromised hosts can be due to more than one pathologic etiology and we should do all diagnostic evaluation to rule out all possible differential diagnosis. introduction cryptococcal meningitis is a rare disorder that is caused by cryptococcus neoformans in immunocompromised host. case presentation the case was a 64-year-old man with a history of stem ce...

Journal: :international journal of pediatrics 0
amir ali hamidieh director of pediatric stem cell transplant program, hematology, oncology and stem cell transplantation research center, director, iranian stem cell donor program (iscdp), tehran university of medical sciences, tehran, iran.

the introduction and evolution of hematopoietic stem cell transplantation (hsct) could be traced back to 1950s, to the studies on interactions among irradiation, covering spleen and bone marrow from it and injection of bone marrow cells. today, hsct is considered a well-established, effective and promising means of therapy for various malignant and non-malignant medical conditions, both in chil...

Fakher Rahim Gholamreza Khamisipour Masoud Soleimani Najmaldin Saki Seyed Hadi Mousavi

Human mesenchymal stem cells (hMSCs), which also called mesenchymal stromal cells, are multipotent stem cell. Human MSCs typically are positive for the surface markers CD44, CD73, CD90, CD105, CD106, and also negative for hematopoietic markers CD34 and CD45.These cells can be isolated from postnatal bone marrow, adipose tissue, placenta, and scalp tissue, as well as from various fetal tissues. ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید